InMed Pharmaceuticals

INM

1.4702.00% ( -0.030 )

已收盘: 7月31日 16:00:00 (美东)

INM

1.4702.00% ( -0.030 )

已收盘: 7月31日 16:00:00 (美东)

主要股东最新
股东
Vivo Capital, LLC	18.32%	81.81 万	--	+81.81 万	2026/07/16
ADAR1 Capital Management, LLC	17.94%	80.10 万	--	+80.10 万	2026/07/15
Daniel Schneeberger	7.42%	33.14 万	--	+33.14 万	2026/05/19
Squadron Capital Management Llc	7.28%	32.50 万	--	+32.50 万	2026/06/30
Sabby Management, LLC	6.27%	28.01 万	1.34%	+5.99 万	2026/06/30
Yorkville Advisors Global LP	1.80%	8.04 万	0.23%	+0	2024/12/13
Citadel Advisors LLC	1.05%	4.70 万	--	+4.70 万	2026/03/31
Virtu Financial, Inc.	0.45%	2.00 万	0.45%	+2.00 万	2026/03/31
Two Sigma Securities, LLC	0.42%	1.87 万	--	+1.87 万	2026/03/31
UBS Asset Management AG	0.18%	8,068.00	0.17%	+7,691.00	2026/03/31
Private Wealth Management Group LLC	0.11%	5,000.00	0.00%	+0	2026/06/30
Eric AdamsPresident, CEO & Director	0.06%	2,794.00	0.01%	+597.00	2026/06/30
Andrew HullIndependent Chair of the Board	0.02%	961.00	0.02%	-951.00	2026/06/30
Shane JohnsonSenior VP & GM of BayMedica	0.01%	608.00	<0.01%	+0	2024/12/20
SBI Holdings, Inc.	<0.01%	300.00	0.00%	+0	2026/06/30
Fédération des caisses Desjardins du Québec	<0.01%	2.00	<0.01%	+0	2026/03/31
Eric HsuSenior Vice President of Preclinical Research & Development	<0.01%	2.00	0.00%	+0	2026/06/30
Michael WoudenbergChief Operating Officer	<0.01%	1.00	0.00%	+0	2026/06/30
N. JagpalCFO & Corporate Secretary	0.00%	0.00	0.00%	+0	2026/06/30
Nicole LemerondIndependent Director	0.00%	0.00	0.00%	+0	2026/06/30

全部股东